INTACT: RetINal Toxicity And HydroxyChloroquine Therapy Study
INTACT: RetINal Toxicity And HydroxyChloroquine Therapy Study Start and end date: January 1, 2021 – December 31, 2023 Overview The INTACT study aims to define the risk of retinal toxicity in patients with rheumatoid arthritis or systemic lupus erythematosus who have been using hydroxychloroquine (also known as Plaquenil) for five or more years. This risk […]
